Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
04/2004
04/01/2004CA2492319A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments
03/2004
03/31/2004EP1403247A1 N-Alkanoylphenylalanine derivatives
03/31/2004EP1401830A2 Quinazolinediones as antibacterial agents
03/31/2004EP1401820A1 5-ht receptor ligands and uses thereof
03/31/2004EP1401819A1 5-ht receptor ligands and uses thereof
03/31/2004EP1401818A2 Targeted multivalent macromolecules
03/31/2004EP1401451A2 Quinazoline derivatives which promote the release of parathyroid hormone
03/31/2004EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar)
03/31/2004EP0981958B1 Insecticidal/acaricidal agents
03/31/2004EP0781766B1 Heterocyclic derivative and medicine
03/31/2004CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis
03/31/2004CN1486170A Couplers for use in oxidative hair dyeing
03/31/2004CN1143853C Preparing method for anti-viral compounds
03/31/2004CN1143679C Method and material for treating and preventing mucosal tissue inflammation
03/31/2004CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
03/30/2004US6713650 ABCA-1 elevating compounds
03/30/2004US6713486 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
03/30/2004US6713485 Antiproliferative agents; side effect reduction
03/30/2004US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
03/25/2004WO2004024703A1 Process for the preparation of 4- (3’-chloro-4’-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline
03/25/2004WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
03/25/2004WO2004024701A1 Heterocyclic derivatives
03/25/2004WO2004024700A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
03/25/2004WO2004024680A1 Alkyl-s-alkyl hydrazone compounds with insecticide, fungicide, herbicide activities and their preparation
03/25/2004WO2004024675A1 Substituted aminoethers for the treatment of alzheimer's disease
03/25/2004WO2004024162A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds
03/25/2004WO2004024161A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properites
03/25/2004WO2004024159A1 INHIBITORS OF TFGβ
03/25/2004WO2004024140A1 Efflux pump inhibitors
03/25/2004WO2004006927A3 Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors
03/25/2004WO2004000820A3 Certain aromatic monocycles as kinase modulators
03/25/2004WO2003069350A3 Small molecule modulators of apoptosis
03/25/2004WO2003041728A8 Novel phenyl-propargylether derivatives
03/25/2004US20040059116 Aryl aniline beta2 adrenergic receptor agonists
03/25/2004US20040059004 10-aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use
03/25/2004US20040058942 Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcuim channel blockers
03/25/2004US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
03/25/2004US20040058937 Heterocyclic mutilin esters and their use as antibacterials
03/25/2004US20040058933 Aryl carbamate derivatives, preperation and use thereof
03/25/2004US20040058913 Cyclic diamine compound with condensed-ring groups
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004CA2498655A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds
03/25/2004CA2498460A1 Inhibitors of tfg.beta.
03/25/2004CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease
03/25/2004CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
03/24/2004EP1400518A1 Heterocyclic compound derivatives and medicines
03/24/2004EP1400516A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage
03/24/2004EP1400510A1 Cyclic diamine compounds having fused-ring groups
03/24/2004EP1400244A1 New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
03/24/2004EP1399428A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
03/24/2004EP1399427A1 Process for the preparation of azoxystrobin and analogues thereof
03/24/2004EP1399426A2 Compounds, compositions and methods for modulating beta-amyloid production
03/24/2004EP1399421A1 Substituted imidates as pesticidal agents
03/24/2004EP1292606A4 Positively-charged peptide nucleic acid analogs with improved properties
03/24/2004EP1131318B1 Process for making 5-substituted pyrazoles using dithietanes
03/24/2004EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/24/2004EP0904079B1 Antidiabetic agents
03/24/2004CN1484634A Alkylthio-and aryl (heteroyl) thio substituted p-phenylenediamines their manufacture and their use in rubber
03/24/2004CN1142936C Condensed thienopyrimidines with phosphodiesterase-V inhibiting action, preparation process and use thereof
03/24/2004CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use
03/24/2004CN1142919C Quinazoline derivatives as antitumor agents
03/24/2004CN1142918C Carboxylic acid derivs, their preparation and their use
03/24/2004CN1142912C Amide derivs, useful as inhibitors for production of cytokines
03/24/2004CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure
03/23/2004US6710178 Preparation of 4-(4-flourophenyl)-6-alkyl-2-N-alkansulfonyl-N-alkylamino)pyrimidine-5-carboxylic acid ester
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/23/2004US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders
03/23/2004US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii.
03/23/2004US6710052 Anticancer agents
03/23/2004US6710045 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (IV)
03/23/2004CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them
03/18/2004WO2004022554A1 Quinazolinone derivatives
03/18/2004WO2004022547A1 Phenethanolamine derivatives and their use in the treatment of respiratory diseases
03/18/2004WO2004022526A1 Cathepsin cysteine protease inhibitors
03/18/2004WO2004022054A1 Pyrazolopyridines and methods of making and using the same
03/18/2004WO2004021989A2 Imidazolopyridines and methods of making and using the same
03/18/2004WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain
03/18/2004WO2003106432A8 Method for producing 4,6-dichloro-5-fluoropyrimidine
03/18/2004WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction
03/18/2004WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
03/18/2004US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders
03/18/2004US20040054181 Chlorination using phospgene; chemical intermediate for drugs, pesticides, fungicides
03/18/2004US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders
03/18/2004US20040053953 Treatment of chemokine mediated diseases
03/18/2004US20040053952 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
03/18/2004US20040053937 Pyrimidine compounds
03/18/2004US20040053927 Certain amino-substituted monocycles as kinase modulators
03/18/2004US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
03/18/2004US20040053815 Inactivating a nuclear localization signal of a protein by contacting the protein with a compound that binds reversibly; parasiticides; viricides
03/18/2004CA2497970A1 Pyrazolopyridines and methods of making and using the same
03/18/2004CA2497968A1 Imidazolopyridines and methods of making and using the same
03/18/2004CA2495939A1 Cathepsin cysteine protease inhibitors
03/17/2004EP1398032A1 4-Oxo-quinazolines as LXR nuclear receptor binding compounds
03/17/2004EP1397505A2 Characterising polypeptides
03/17/2004EP1397351A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
03/17/2004EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
03/17/2004EP1244634B1 Substituted benzoylcyclohexane diones for use as herbicides
03/17/2004EP1135391B1 Novel triazolo(4,5-d)pyrimidine compounds
03/17/2004CN1483019A Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
03/17/2004CN1142150C Pyrimidinoxy salicylic acid derivative